CIK: 1396482 - Address: One Amgen Center Drive, Thousand Oaks, CA 91320-1799
9 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

P%ret11101514454722
P%wins100100100100100100100
S%ret1121-14715116
S%wins50500005025

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

2/22/21 19:27
2/18/21
AMGNAmgen IncDEHealthBioPrdBiological Products, (No DiagBradway Robert ACADOCB,CEO,PM.d4,02054.6907415571D
4/13/20 19:54
4/13/20
AMGNAmgen IncDEHealthBioPrdBiological Products, (No DiagBradway Robert ACADOCB,CEO,PM.d7,42158.43012731540D
3/4/16 18:07
3/2/16
AMGNAmgen IncDEHealthBioPrdBiological Products, (No DiagBradway Robert ACADOCB,CEO,PM.d4,23750.44338426403D21-60-9-43-131-36101827
3/4/16 18:07
3/2/16
AMGNAmgen IncDEHealthBioPrdBiological Products, (No DiagBradway Robert ACADOCB,CEO,PS.d-2,930146.4833-20-5403D21-60-9-43-131-36101827
2/12/15 21:09
2/11/15
AMGNAmgen IncDEHealthBioPrdBiological Products, (No DiagBradway Robert ACADOCB,CEO,PM.d3,53942.13338463218D872922-6-4-412021412-6
2/12/15 21:09
2/11/15
AMGNAmgen IncDEHealthBioPrdBiological Products, (No DiagBradway Robert ACADOCB,CEO,PS.d-3,359152.6933-22-9218D872922-6-4-412021412-6
5/12/14 20:33
5/12/14
AMGNAmgen IncDEHealthBioPrdBiological Products, (No DiagBradway Robert ACADOCB,CEO,PP100111.773310185D669-1-6-8-50-1015144547
2/14/14 16:19
2/12/14
AMGNAmgen IncDEHealthBioPrdBiological Products, (No DiagBradway Robert ACADOCB,CEO,PM.d4,06662.55336563169D924918118584100-10826
12/20/12 18:34
12/20/12
AMGNAmgen IncDEHealthBioPrdBiological Products, (No DiagBradway Robert ACADOP,CEOM.d2,58264.56334059107D595022840-1-1-1-3-6101230

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact